![]() |
Name |
Dothideomynone B
|
Molecular Formula | C18H18O7 | |
IUPAC Name* |
(7R,8S)-7,8-dihydroxy-5-[(4-hydroxy-6-methyl-2-oxopyran-3-yl)methyl]-3,7-dimethyl-8H-isochromen-6-one
|
|
SMILES |
CC1=CC2=C(C(=O)[C@]([C@H](C2=CO1)O)(C)O)CC3=C(C=C(OC3=O)C)O
|
|
InChI |
InChI=1S/C18H18O7/c1-8-4-10-11(6-12-14(19)5-9(2)25-17(12)22)15(20)18(3,23)16(21)13(10)7-24-8/h4-5,7,16,19,21,23H,6H2,1-3H3/t16-,18-/m0/s1
|
|
InChIKey |
JAICSOGYASYZMJ-WMZOPIPTSA-N
|
|
Synonyms |
Dothideomynone B; CHEMBL3358715; (7R,8S)-7,8-dihydroxy-5-[(4-hydroxy-6-methyl-2-oxo-pyran-3-yl)methyl]-3,7-dimethyl-8H-isochromen-6-one
|
|
CAS | NA | |
PubChem CID | 118723029 | |
ChEMBL ID | CHEMBL3358715 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 346.3 | ALogp: | -0.3 |
HBD: | 3 | HBA: | 7 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 113.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 25 | QED Weighted: | 0.742 |
Caco-2 Permeability: | -4.871 | MDCK Permeability: | 0.00001920 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.352 |
Human Intestinal Absorption (HIA): | 0.067 | 20% Bioavailability (F20%): | 0.012 |
30% Bioavailability (F30%): | 0.007 |
Blood-Brain-Barrier Penetration (BBB): | 0.558 | Plasma Protein Binding (PPB): | 81.27% |
Volume Distribution (VD): | 1.04 | Fu: | 15.48% |
CYP1A2-inhibitor: | 0.807 | CYP1A2-substrate: | 0.327 |
CYP2C19-inhibitor: | 0.148 | CYP2C19-substrate: | 0.23 |
CYP2C9-inhibitor: | 0.407 | CYP2C9-substrate: | 0.224 |
CYP2D6-inhibitor: | 0.179 | CYP2D6-substrate: | 0.136 |
CYP3A4-inhibitor: | 0.367 | CYP3A4-substrate: | 0.411 |
Clearance (CL): | 1.556 | Half-life (T1/2): | 0.758 |
hERG Blockers: | 0.033 | Human Hepatotoxicity (H-HT): | 0.601 |
Drug-inuced Liver Injury (DILI): | 0.941 | AMES Toxicity: | 0.209 |
Rat Oral Acute Toxicity: | 0.975 | Maximum Recommended Daily Dose: | 0.948 |
Skin Sensitization: | 0.714 | Carcinogencity: | 0.896 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.026 |
Respiratory Toxicity: | 0.973 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003643 | ![]() |
0.554 | D0FA2O | ![]() |
0.267 | ||
ENC003108 | ![]() |
0.493 | D0J2NK | ![]() |
0.254 | ||
ENC003634 | ![]() |
0.371 | D08NQZ | ![]() |
0.248 | ||
ENC003420 | ![]() |
0.358 | D02TJS | ![]() |
0.243 | ||
ENC002743 | ![]() |
0.347 | D0S0LZ | ![]() |
0.238 | ||
ENC005436 | ![]() |
0.340 | D0G4KG | ![]() |
0.237 | ||
ENC005435 | ![]() |
0.340 | D0R6RC | ![]() |
0.234 | ||
ENC003987 | ![]() |
0.338 | D02PMO | ![]() |
0.234 | ||
ENC001876 | ![]() |
0.337 | D02GAC | ![]() |
0.233 | ||
ENC003803 | ![]() |
0.333 | D0Z4XW | ![]() |
0.232 |